[HTML][HTML] Preventing measles in immunosuppressed cancer and hematopoietic cell transplantation patients: a position statement by the American Society for …

SA Pergam, JA Englund, M Kamboj, HA Gans… - Biology of Blood and …, 2019 - Elsevier
Until recently, measles exposures were relatively rare and so, consequently, were an
afterthought for cancer patients and/or blood and marrow transplant recipients and their …

A systematic review and modelling insights of factors impacting measles vaccine effectiveness

S Ghosh, D Kappara, N Majumder, S Nath-Sain… - medRxiv, 2024 - medrxiv.org
Background & objectives: Outbreaks of measles have been frequently reported despite the
availability of an effective vaccine. In this systematic review we examine the potential factors …

Seroprevalence of measles and mumps antibodies among individuals with cancer

SR Marquis, JK Logue, HY Chu, T Loeffelholz… - JAMA Network …, 2021 - jamanetwork.com
Importance Although patients with cancer are at an increased risk of infection-related
complications, few studies have characterized their vulnerability to measles and mumps …

Measles, mumps, and rubella revaccination in children after completion of chemotherapy and hematopoietic stem cell transplantation: a single-center prospective …

M Wang, Q Yuan, PF Deng, Y Fei, H Zhang… - World Journal of …, 2023 - Springer
Background Chemotherapy and hematopoietic stem cell transplantation (HSCT) can
damage the immune system, and may result in a loss of protection from infectious diseases …

Immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors

E Toret, SE Yel, M Suman, Y Duzenli Kar… - Human vaccines & …, 2021 - Taylor & Francis
Intensive chemotherapy can cause long-lasting immunosuppression in children who
survived cancer. The immunosuppression varies according to the type of cancer, intensity of …

Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy

A Anafy, G Gilad, N Michaan, R Elhasid… - Pediatric Blood & …, 2023 - Wiley Online Library
Background Intensive chemotherapy for acute lymphoblastic leukemia (ALL) may affect the
immune system and potentially the immune memory causing antibodies provided by …

Assessment of humoral immunity to measles virus in cancer survivor children after chemotherapy: a case-control study

TA Abdelaziz, M Atfy, AI Risha… - Fetal and Pediatric …, 2022 - Taylor & Francis
Background This case-control study was conducted to determine the antibody titer against
the measles virus in childhood cancer survivors' post-chemotherapy treatment to determine …

Assessment of Antibody Levels and Vaccine-induced Serologic Responses After Completion of Cancer Treatment in Pediatric Patients: A 6-Year Experience in Turkey …

SS Gundesli, M Celik, SS Yalcin, GB Aydin… - Journal of Pediatric …, 2025 - journals.lww.com
Objective: Childhood cancer treatment disrupts vaccination schedules and weakens or
eliminates vaccine-induced immunity. In addition, post-treatment vaccine responses vary …

Seroprevalence of Measles (Rubeola) Antibodies in Childhood Cancer Survivors

DB Crom, LA Walters, Y Li, J Liang… - Journal of Pediatric …, 2024 - journals.sagepub.com
Background: Measles is reemerging as a public health threat, raising important questions
about disease vulnerability among childhood cancer survivors. This secondary analysis …

Real-world vaccination status of children with hematologic tumors before and after chemotherapy

C Ji, H Shen, M Li, Y Liu, X Zhang, J Guo… - Expert Review of …, 2023 - Taylor & Francis
Background There is a high incidence and mortality rate in children with hematologic tumors
(CHT), who are more prone to various infectious diseases. This study aims to clarify the real …